Na Lu

9.3k total citations · 1 hit paper
199 papers, 7.7k citations indexed

About

Na Lu is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Na Lu has authored 199 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 119 papers in Molecular Biology, 78 papers in Pharmacology and 45 papers in Oncology. Recurrent topics in Na Lu's work include Flavonoids in Medical Research (49 papers), Cancer-related Molecular Pathways (23 papers) and Natural Compound Pharmacology Studies (23 papers). Na Lu is often cited by papers focused on Flavonoids in Medical Research (49 papers), Cancer-related Molecular Pathways (23 papers) and Natural Compound Pharmacology Studies (23 papers). Na Lu collaborates with scholars based in China, United States and Hong Kong. Na Lu's co-authors include Qinglong Guo, Qidong You, Qi Qi, Zhiyu Li, Yong Yang, Li Zhao, Yun Ling, Hong-Yan Gu, Xiuming Song and Qinsheng Dai and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Na Lu

197 papers receiving 7.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Application of Ferroptosis in Diseases

2020 328 citations Na Lu et al. profile →

Peers

Countries citing papers authored by Na Lu

Since Specialization

Citations

This map shows the geographic impact of Na Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Na Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Na Lu more than expected).

Fields of papers citing papers by Na Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Na Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Na Lu. The network helps show where Na Lu may publish in the future.

Co-authorship network of co-authors of Na Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Na Lu. A scholar is included among the top collaborators of Na Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Na Lu. Na Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Machine learning-based prognostic model for bloodstream infections in hematological malignancies using Th1/Th2 cytokines 2025 ·BMC Infectious Diseases ·Qin Li, Nan Lin, (unknown), Yuexi Chen, (unknown), Xuemei Wang, (unknown), (unknown), Min Xu, Na Lu, Yan Huang, Jiamin Luo, Zhenfang Liu, Jing Li	1
2	Metabolomics Analysis of the Mechanism of Yuquan Capsules in the Treatment of T2DM Rats Using UPLC/MS 2025 ·Diabetes Metabolic Syndrome and Obesity ·Mengli Zhang, (unknown), Min Ou, Taiping Li, (unknown), Lu Chen, Rui Xiao, Na Lu, Xijun Wang, Fangfang Wu	1
3	Fabrication of docetaxel-loaded hyaluronic acid coated zeolitic imidazolate framework‑8 as an effective treatment for leukaemia cancer cells and its apoptosis induction 2024 ·Journal of Experimental Nanoscience ·(unknown), (unknown), Di Su, Na Lu	2
4	Gambogic acid impairs the maintenance and therapeutic resistance of glioma stem cells by targeting B-cell-specific Moloney leukemia virus insert site 1 2024 ·Phytomedicine ·(unknown), Binyan Lin, (unknown), Xueyan Zhang, (unknown), J.‐M. Yang, (unknown), Hong Lu, Na Lu, Kai Zhao	5
5	Extracellular ATP contributes to the reactive oxygen species burst and exaggerated mitochondrial damage in D-galactosamine and lipopolysaccharide-induced fulminant hepatitis 2024 ·International Immunopharmacology ·Rong Xu, (unknown), (unknown), Na Lu, Yaping Li, (unknown), Bo Hu, (unknown), Xian‐Hui He, Qingbing Zha, Dong‐Yun Ouyang	5
6	Baicalin inhibits PANoptosis by blocking mitochondrial Z-DNA formation and ZBP1-PANoptosome assembly in macrophages 2024 ·Acta Pharmacologica Sinica ·(unknown), Yan Liang, (unknown), Yaping Li, Zijian Shi, (unknown), Haiyan Yang, (unknown), (unknown), Na Lu, Lihui Xu, Bo Hu, Dong‐Yun Ouyang, Qingbing Zha, Xian‐Hui He	33
7	Modulation of oxidized low-density lipoprotein-affected macrophage efferocytosis by mitochondrial calcium uniporter in a murine model 2023 ·Immunology Letters ·Na Lu, (unknown), (unknown), Haipeng Zhang, (unknown), Jingjing Yang, Xian‐Wei Wang	7
8	Potassium ion efflux induces exaggerated mitochondrial damage and non-pyroptotic necrosis when energy metabolism is blocked 2023 ·Free Radical Biology and Medicine ·Rong Xu, (unknown), (unknown), Na Lu, Yaping Li, (unknown), Qingbing Zha, Xian‐Hui He, (unknown), Dong‐Yun Ouyang	12
9	TRAF4 Maintains Deubiquitination of Caveolin-1 to Drive Glioblastoma Stemness and Temozolomide Resistance 2022 ·Cancer Research ·(unknown), (unknown), Quan Wan, Qing Wang, Zhenzhong Chen, Yuan Gao, (unknown), Jiusheng Lin, (unknown), (unknown), Jinming Yang, Kai Zhao, Na Lu	25
10	Effects of curcumin‐based photodynamic method on protein degradation of oysters 2021 ·International Journal of Food Science & Technology ·Na Lu, Zhiguang Wang, Xu Zhang, Fang Liu, Yuan Gao, Zhaojie Li, Changhu Xue, Qingjuan Tang	6
11	YIPF6 controls sorting of FGF21 into COPII vesicles and promotes obesity 2019 ·Proceedings of the National Academy of Sciences ·Lirui Wang, Magdalena Mazagova, Chuyue Pan, Song Yang, Katharina Brandl, Jun Liu, Shannon M. Reilly, Yanhan Wang, (unknown), Rohit Loomba, Na Lu, Qinglong Guo, Jihua Liu, Ruth T. Yu, Michael Downes, Ronald M. Evans, David A. Brenner, Alan R. Saltiel, Bruce Beutler, Bernd Schnabl	29
12	Reactive oxygen species-responsive nanoprodrug with quinone methides-mediated GSH depletion for improved chlorambucil breast cancers therapy 2018 ·Journal of Controlled Release ·(unknown), Yuxin Zhou, Tian‐Jiao Zhou, Lei Xing, Peng‐Fei Cui, Minjie Sun, 良樹鷹津, Na Lu, Hu‐Lin Jiang	83
13	Oroxylin A inhibits invasion and migration through suppressing ERK/GSK‐3β signaling in snail‐expressing non‐small‐cell lung cancer cells 2016 ·Molecular Carcinogenesis ·Libin Wei, Yuyuan Yao, Kai Zhao, Yujie Huang, Yuxin Zhou, Li Zhao, Qinglong Guo, Na Lu	32
14	Oroxylin A, a natural anticancer flavonoid compound, induces differentiation of t(8;21)-positive Kasumi-1 and primary acute myeloid leukemia cells 2016 ·Journal of Cancer Research and Clinical Oncology ·Hui Hui, Xiaoxiao Zhang, Hui Li, (unknown), Le Shen, Yu Zhu, Jingyan Xu, Qinglong Guo, Na Lu	16
15	Wogonoside inhibits angiogenesis in breast cancer via suppressing Wnt/β‐catenin pathway 2015 ·Molecular Carcinogenesis ·Yujie Huang, Kai Zhao, Yang Hu, Yuxin Zhou, (unknown), Xiaorui Li, Libin Wei, Zhiyu Li, Qidong You, Qinglong Guo, Na Lu	42
16	Oroxylin A regulates glucose metabolism in response to hypoxic stress with the involvement of Hypoxia‐inducible factor‐1 in human hepatoma HepG2 cells 2015 ·Molecular Carcinogenesis ·Qinsheng Dai, Qian Yin, Libin Wei, Yuxin Zhou, Chen Qiao, Yongjian Guo, Xuemin Wang, Shiping Ma, Na Lu	32
17	Two p53-related metabolic regulators, TIGAR and SCO2, contribute to oroxylin A-mediated glucose metabolism in human hepatoma HepG2 cells 2013 ·The International Journal of Biochemistry & Cell Biology ·Qinsheng Dai, (unknown), Wei Liu, Libin Wei, Yuxin Zhou, Zhiyu Li, Qidong You, Na Lu, Qinglong Guo	33
18	Wogonin inhibits tumor angiogenesis via degradation of HIF-1α protein 2013 ·Toxicology and Applied Pharmacology ·Xiuming Song, Jing Yao, Fei Wang, Mi Zhou, Yuxin Zhou, Hu Wang, Libin Wei, Li Zhao, Zhiyu Li, Na Lu, Qinglong Guo	66
19	Inhibitory effects of GL-V9 on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix metalloproteinase-2/9 2011 ·European Journal of Pharmaceutical Sciences ·Liwen Li, Pu Chen, Yun Ling, Xiuming Song, Zhijian Lu, (unknown), Zhiyu Li, Na Lu, Qinglong Guo	35
20	Studies on the toxicity of gambogic acid in rats 2008 ·Journal of Ethnopharmacology ·Qi Qi, Qidong You, Hong-Yan Gu, Li Zhao, Wei Liu, Na Lu, Qinglong Guo	68

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact